Mankind Pharma to acquire 70% in Belgian biotech firm for €48 million
Deal marks entry into next-generation CAR-T cancer therapies as company expands global innovation ambitions
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.